KCNJ1
ATP-sensitive inward rectifier potassium channel 1
Also known as: KCNJ1_HUMAN, Kir1.1, ROMK1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48048
- Gene
- KCNJ1
- Ensembl
- ENSG00000151704
- Chromosome
- 11
- Canonical length
- 391 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels
OverviewNCBI Gene
Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. It is activated by internal ATP and probably plays an important role in potassium homeostasis. The encoded protein has a greater tendency to allow potassium to flow into a cell rather than out of a cell. Mutations in this gene have been associated with antenatal Bartter syndrome, which is characterized by salt wasting, hypokalemic alkalosis, hypercalciuria, and low blood pressure. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
391 residues, UniProt reviewed canonical sequence.
>P48048|KCNJ1
1 MNASSRNVFD TLIRVLTESM FKHLRKWVVT RFFGHSRQRA RLVSKDGRCN IEFGNVEAQS
61 RFIFFVDIWT TVLDLKWRYK MTIFITAFLG SWFFFGLLWY AVAYIHKDLP EFHPSANHTP
121 CVENINGLTS AFLFSLETQV TIGYGFRCVT EQCATAIFLL IFQSILGVII NSFMCGAILA
181 KISRPKKRAK TITFSKNAVI SKRGGKLCLL IRVANLRKSL LIGSHIYGKL LKTTVTPEGE
241 TIILDQININ FVVDAGNENL FFISPLTIYH VIDHNSPFFH MAAETLLQQD FELVVFLDGT
301 VESTSATCQV RTSYVPEEVL WGYRFAPIVS KTKEGKYRVD FHNFSKTVEV ETPHCAMCLY
361 NEKDVRARMK RGYDNPNFIL SEVNETDDTK MLocalizationUniProt · AlphaFold · HPA
Whether an antibody against KCNJ1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.36
- Highest tissue expression
- 185 nTPM
Expression across tissuesHPA
Tissue
- kidney: 185 nTPM
- basal ganglia: 4.5 nTPM
- epididymis: 1.4 nTPM
- amygdala: 1 nTPM
- skin: 1 nTPM
- seminal vesicle: 0.9 nTPM
Single-cell type
- distal convoluted tubule cells: 235 nCPM
- renal connecting tubule cells: 192 nCPM
- loop of henle epithelial cells: 159 nCPM
- renal collecting duct principal cells: 32 nCPM
- renal collecting duct intercalated cells: 16 nCPM
- podocytes: 15 nCPM
Immune cell
- memory B-cell: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- basal ganglia: 3.3 nTPM
- amygdala: 2 nTPM
- hippocampal formation: 1 nTPM
- cerebral cortex: 0.6 nTPM
- thalamus: 0.6 nTPM
- medulla oblongata: 0.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about KCNJ1.
Disease | AllUniProt
Conditions KCNJ1 is implicated in, by any mechanism.
- Bartter syndrome 2, antenatal (BARTS2) MIM:241200
Disease | GeneticClinVar
77 pathogenic / likely-pathogenic of 351 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Bartter disease type 2
- Bartter syndrome
- Renal tubulopathies
- KCNJ1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.29
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.28
- DepMap mean gene effect
- 0.17
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- circulatory system development
- gene expression
- kidney development
- monoatomic ion transport
- post-embryonic development
- potassium ion import across plasma membrane
- regulation of monoatomic ion transmembrane transport
- renal sodium ion absorption
- tissue homeostasis
Molecular functions
- ATP binding
- ATP-activated inward rectifier potassium channel activity
- inward rectifier potassium channel activity
- phosphatidylinositol-4,5-bisphosphate binding
- potassium channel activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Potassium channel, inwardly rectifying, Kir, cytoplasmic
- Immunoglobulin E-set
- Potassium channel, inwardly rectifying, Kir
- Potassium channel, inwardly rectifying, transmembrane domain
- Inward rectifier potassium channel, C-terminal
- Inward rectifier potassium channel transmembrane domain
- Inward rectifier potassium channel C-terminal domain
- FPotassium channel, inwardly rectifying, Kir1.1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KCNJ1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KCNJ1 as an antibody target. Whether an autoantibody or antibody against KCNJ1 could matter depends on whether native KCNJ1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KCNJ1 is annotated at the cell surface, where native KCNJ1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KCNJ1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...